These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9630553)

  • 21. Structure-based virtual screening as a tool for the identification of novel inhibitors against Mycobacterium tuberculosis 3-dehydroquinate dehydratase.
    Petersen GO; Saxena S; Renuka J; Soni V; Yogeeswari P; Santos DS; Bizarro CV; Sriram D
    J Mol Graph Model; 2015 Jul; 60():124-31. PubMed ID: 26043661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis and characterization of dual inhibitors against new targets FabG4 and HtdX of Mycobacterium tuberculosis.
    Banerjee DR; Biswas R; Das AK; Basak A
    Eur J Med Chem; 2015 Jul; 100():223-34. PubMed ID: 26092447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of scytalone dehydratase inhibitors as rice blast fungicides: (N-phenoxypropyl)-carboxamides.
    Jordan DB; Lessen TA; Wawrzak Z; Bisaha JJ; Gehret TC; Hansen SL; Schwartz RS; Basarab GS
    Bioorg Med Chem Lett; 1999 Jun; 9(11):1607-12. PubMed ID: 10386945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitors of types I and II dehydroquinase.
    Le Sann C; Gower MA; Abell AD
    Mini Rev Med Chem; 2004 Sep; 4(7):747-56. PubMed ID: 15379642
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heterocyclic inhibitors of dihydrodipicolinate synthase are not competitive.
    Turner JJ; Gerrard JA; Hutton CA
    Bioorg Med Chem; 2005 Mar; 13(6):2133-40. PubMed ID: 15727866
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Rational design of new bifunctional inhibitors of type II dehydroquinase.
    Toscano MD; Stewart KA; Coggins JR; Lapthorn AJ; Abell C
    Org Biomol Chem; 2005 Sep; 3(17):3102-4. PubMed ID: 16106291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel 17-azolyl steroids, potent inhibitors of human cytochrome 17 alpha-hydroxylase-C17,20-lyase (P450(17) alpha): potential agents for the treatment of prostate cancer.
    Njar VC; Kato K; Nnane IP; Grigoryev DN; Long BJ; Brodie AM
    J Med Chem; 1998 Mar; 41(6):902-12. PubMed ID: 9526564
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational design, synthesis, and evaluation of nanomolar type II dehydroquinase inhibitors.
    Payne RJ; Peyrot F; Kerbarh O; Abell AD; Abell C
    ChemMedChem; 2007 Jul; 2(7):1015-29. PubMed ID: 17487900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative structure-activity relationships for phenyl triazolinones of protoporphyrinogen oxidase inhibitors: a density functional theory study.
    Wan J; Zhang L; Yang G
    J Comput Chem; 2004 Nov; 25(15):1827-32. PubMed ID: 15389747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.
    Jafari B; Ospanov M; Ejaz SA; Yelibayeva N; Khan SU; Amjad ST; Safarov S; Abilov ZA; Turmukhanova MZ; Kalugin SN; Ehlers P; Lecka J; Sévigny J; Iqbal J; Langer P
    Eur J Med Chem; 2018 Jan; 144():116-127. PubMed ID: 29268128
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.
    Prazeres VF; Tizón L; Otero JM; Guardado-Calvo P; Llamas-Saiz AL; van Raaij MJ; Castedo L; Lamb H; Hawkins AR; González-Bello C
    J Med Chem; 2010 Jan; 53(1):191-200. PubMed ID: 19911771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and multiparametric evaluation of thiadiazoles and oxadiazoles as diacylglycerol acyltransferase type 1 inhibitors.
    Mougenot P; Namane C; Fett E; Goumy F; Dadji-Faïhun R; Langot G; Monseau C; Onofri B; Pacquet F; Pascal C; Crespin O; Ben-Hassine M; Ragot JL; Van-Pham T; Philippo C; Chatelain-Egger F; Péron P; Le Bail JC; Guillot E; Chamiot-Clerc P; Chabanaud MA; Pruniaux MP; Ménegotto J; Schmidt F; Venier O; Viviani F; Nicolai E
    Bioorg Med Chem Lett; 2016 Jan; 26(1):25-32. PubMed ID: 26627579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and study of the α-amylase inhibitory potential of thiadiazole quinoline derivatives.
    Taha M; Tariq Javid M; Imran S; Selvaraj M; Chigurupati S; Ullah H; Rahim F; Khan F; Islam Mohammad J; Mohammed Khan K
    Bioorg Chem; 2017 Oct; 74():179-186. PubMed ID: 28826047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-pot synthesis of new triazole--Imidazo[2,1-b][1,3,4]thiadiazole hybrids via click chemistry and evaluation of their antitubercular activity.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4169-73. PubMed ID: 26298500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis, crystal structure and biological evaluation of some novel 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazoles and 1,2,4-triazolo[3,4-b]-1,3,4-thiadiazines.
    Khan I; Zaib S; Ibrar A; Rama NH; Simpson J; Iqbal J
    Eur J Med Chem; 2014 May; 78():167-77. PubMed ID: 24681981
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Novel Class of Triazolo-Thiadiazoles as Potent Inhibitors of Human Heparanase and their Anticancer Activity.
    Baburajeev CP; Mohan CD; Rangappa S; Mason DJ; Fuchs JE; Bender A; Barash U; Vlodavsky I; Basappa ; Rangappa KS
    BMC Cancer; 2017 Mar; 17(1):235. PubMed ID: 28359266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A new potent inhibitor of fungal melanin biosynthesis identified through combinatorial chemistry.
    Jennings LD; Wawrzak Z; Amorose D; Schwartz RS; Jordan DB
    Bioorg Med Chem Lett; 1999 Sep; 9(17):2509-14. PubMed ID: 10498198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular docking studies and biological evaluation of 1,3,4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors.
    Tang J; Liu J; Wu F
    Bioorg Chem; 2016 Dec; 69():29-36. PubMed ID: 27669118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1,3-Phenylene bis(ketoacid) derivatives as inhibitors of Escherichia coli dihydrodipicolinate synthase.
    Boughton BA; Hor L; Gerrard JA; Hutton CA
    Bioorg Med Chem; 2012 Apr; 20(7):2419-26. PubMed ID: 22386717
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of [1,2,4]triazolo[3,4-b][1,3,4]thiadiazole derivatives as novel, potent and selective c-Met kinase inhibitors: Synthesis, SAR study, and biological activity.
    Zhang L; Zhao J; Zhang B; Lu T; Chen Y
    Eur J Med Chem; 2018 Apr; 150():809-816. PubMed ID: 29602036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.